Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 35.10 NOK
Change Today +0.10 / 0.29%
Volume 17.8K
PHO On Other Exchanges
As of 6:46 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

photocure asa (PHO) Snapshot

35.50 NOK
Previous Close
35.00 NOK
Day High
36.40 NOK
Day Low
35.10 NOK
52 Week High
01/12/15 - 39.00 NOK
52 Week Low
11/4/14 - 17.70 NOK
Market Cap
Average Volume 10 Days
-0.78 NOK
Shares Outstanding
Dividend Yield
Current Stock Chart for PHOTOCURE ASA (PHO)

Related News

No related news articles were found.

photocure asa (PHO) Related Businessweek News

No Related Businessweek News Found

photocure asa (PHO) Details

Photocure ASA is engaged in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment. The company markets Hexvix/Cysview for the detection of bladder cancer. Its products pipeline includes Visonac that has completed phase 2b study for the treatment of moderate to severe acne; Cevira, which has completed phase 2b study for the treatment of human papilloma virus disease and precancerous lesions of the cervix; and Lumacan that is under phase 1/2 development for the detection of colorectal cancer. The company sells its products to license partners, pharmaceutical wholesalers, and hospitals. The company operates in Norway, Sweden, Denmark, Finland, and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.

47 Employees
Last Reported Date: 04/9/15
Founded in 1997

photocure asa (PHO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

photocure asa (PHO) Key Developments

PhotoCure ASA Approves Amendment to Articles of Association

PhotoCure ASA announced that at its annual general meeting held on April 30, 2015, approved amendment of the company's articles of association.

PhotoCure ASA Approves Board Appointments

PhotoCure ASA held its annual general meeting on April 30, 2015. At the meeting the shareholders approved appointment of Tom Pike as board member and approved appointment of Hans Peter Bohn, Beate Bredesen and Jams McDonald as members to the nomination committee.

PhotoCure ASA Reports Audited Parent Company and Group Earnings Results for the Year Ended December 31, 2014

Photocure ASA reported audited parent company and group earnings results for the year ended December 31, 2014. For the year, the parent company reported sales revenues of NOK 93.913 million against NOK 64.224 million a year ago. Total Revenue was NOK 129.279 million against NOK 68.533 million a year ago. Operating profit was NOK 28.091 million against operating loss of NOK 48.498 million a year ago. Profit before tax was NOK 58.302 million against loss before tax of NOK 35.305 million a year ago. Net profit for the year was NOK 40.255 million against net loss for the year of NOK 27.036 million a year ago. Net cash flow from operating activities was NOK 27.974 million against net cash flow used in operating activities of NOK 79.094 million a year ago. Investments in machinery and equipment was NOK 0.956 million against NOK 1.085 million a year ago. For the year, the group reported loss before tax of NOK 6.653 million against NOK 66.852 million a year ago. Net loss for the year was NOK 24.700 million or NOK 1.16 per basic share against NOK 58.950 million or NOK 2.76 per basic share a year ago. Investments in machinery and equipment was NOK 0.956 million against NOK 1.085 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHO:NO 35.10 NOK +0.10

PHO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHO.
View Industry Companies

Industry Analysis


Industry Average

Valuation PHO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.7x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHOTOCURE ASA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at